The value of genetics in the era of hepatitis C triple therapy

Despite the introduction of protease inhibitors (PI) in the treatment of hepatitis C, the sensitivity of interferon continues to be essential to achieve a sustained virological response (SVR) and to eradicate the viral infection. Currently, pegylated interferon (PEG-IFN) and ribavirin (RBV) are requ...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Gastroenterología y hepatología 2014-08, Vol.37 (7), p.427-437
Hauptverfasser:	Quiles-Pérez, Rosa, Pavón-Castillero, Esther José, Muñoz-de-Rueda, Paloma, Carmona, Isabel, Salmerón, Javier
Format:	Artikel
Sprache:	spa
Schlagworte:	Anemia - etiology Antiviral Agents - administration & dosage Drug Therapy, Combination Genotype Hepacivirus - genetics Hepatitis C, Chronic - complications Hepatitis C, Chronic - drug therapy Hepatitis C, Chronic - virology Humans Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!